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Meta-analysisIntroduction: Previousmeta-analyses showed that OCD is associatedwith a substantial risk of suicidal behaviours.
Conclusive rates of suicidal ideation (current and lifetime) and suicide attempts based on pooled prevalence rates
have not so far been calculated usingmeta-analysis for the other DSM-5 Obsessive-Compulsive and Related Dis-
orders (OCRDs).
Objectives: This meta-analysis aims to separately calculate the pooled prevalence rates of lifetime suicide at-
tempts and current or lifetime suicidal ideation in BDD, Hoarding Disorder (HD), Skin Picking Disorder (SPD)
and Trichotillomania (TTM) and to identify factors associated with increased suicide rates.
Methods: Our protocol was pre-registered with PROSPERO (CRD42020164395). A systematic review and meta-
analysis following PRISMA reporting guidelines was performed by searching in PubMed/Medline, PsycINFO,
Web of Science and CINAHL databases from the date of the first available article to April 20th, 2020. Stata version
15was used for the statistical analysis. Given the small number of studies in TTM and SPD, the two grooming dis-
orders were grouped together. Meta-analyses of proportions based on random effects (Der-Simonian and Laird
method) were used to derive the pooled estimates.
Results: Thirty-eigth studies (N=4559 participants) were included: 23 for BDD, 8 for HD, 7 for Grooming Disor-
ders. For BDD, the pooled prevalence of lifetime suicide attempts, current and lifetime suicidal ideation was, re-
spectively 35.2% (CI:23.4–47.8), 37.2% (CI:23.8–51.6) and 66.1% (CI:53.5–77.7). For HD, the pooled prevalence of
lifetime suicide attempts, current and lifetime suicidal ideation was 24.1% (CI:12.8–37.6), 18.4% (CI:10.2–28.3)
and 38.3% (CI:35.0–41.6), respectively. For Grooming Disorders, the pooled prevalence of lifetime suicide at-
tempts and current suicidal ideation were 13.3% (CI:5.9–22.8) and 40.4% (CI:35.7–45.3), respectively (no data
available for lifetime suicidal ideation).
Conclusions: The OCRDs as a group are associated with relatively high rates of suicidal behaviour. Through indi-
rect comparisons, we infer that BDD has the greatest risk. Comorbid substance abuse, possibly reflecting poor un-
derlying impulse control, is associated with higher rates of suicidal behaviour in BDD. Our data emphasize the
need for clinicians to consider the risk of suicidal behaviour in the management of patients presenting with all
forms of OCRDs.
© 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obsessive-Compulsive Disorder (OCD) is a common, chronic and
relatively treatment resistant neuropsychiatric disorder [3]. OCD is thedical Sciences, University of
script.
. This is an open access article undernosological organizer of an emerging family or spectrum of disorders,
named in the Diagnostic and Statistical Manual of Mental Disorders,
5th Edition (DSM-5). chapter as Obsessive Compulsive and Related
Disorders (OCRDs). These other disorders are: Body Dysmorphic Disor-
der (BDD), Hoarding Disorder (HD), Skin Picking Disorder (SPD) and
Trichotillomania (TTM). They are defined by the presence of obsessions
and/or compulsions, alongside shared psychopathological and neurobi-
ological features and are characterized by compulsive, impulsive and
habitual behaviours [4]. Indeed, whereas all the disorders included inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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appear, phenotypically, to have a stronger cognitive and affective
component – and thus appear closer to OCD – while others such as
TTM and SPD are predominantly characterized by body-focused repeti-
tive behaviours suggesting a stronger impulsive or habitual motor
component [5].
OCRDs often start in childhood and follow a fluctuating lifelong
course. They have an extensive impact on the quality of life, well-
being and global functioning of affected individuals and their family
members [6,7]. Both OCD and BDD have been found to be associated
with a relatively long delay in help seeking (up to 11 years for OCD)
[8,9], with OCD having a duration of untreated illness (DUI) recently
estimated at 7 to 9 years, i.e. one of the longest among psychiatric disor-
ders [10–12]. The chronicity, delay in help-seeking and long duration of
untreated illness is thought to contribute to the development of second-
ary psychiatric conditions such as depression [13]. Indeed, secondary
depression in OCD develops in roughly 60% of cases and correlates
with duration of illness [13], thereby potentially increasing suicide risk.
Suicide is a major preventable cause of premature death worldwide,
and research on factors associated with suicidal ideation and behaviour
in individuals with mental disorders is imperative. Suicidal ideation is
defined as the presence of passive thoughts about wanting to be dead
or active thoughts about killing oneself, not accompanied by prepara-
tory behaviour [14]; suicide attempts are recognized as nonfatal
self-directed potentially injurious behaviours with any intent to die as
a result of the behaviour [15].
OCRDs were historically thought not to be related to an elevated
suicide risk [16–18]. Recent systematic reviews and meta-analyses,
however, have challenged this assumption and suggested that individ-
uals with OCD are at a substantially higher risk of suicide attempts
and suicidal ideation than the general population [1,19–24,110]. Accu-
rate pooled rates of suicide attempts and suicidal ideation in individuals
with a primary diagnosis of OCD were identified by a recent meta-
analysis from our research group [1]: the pooled prevalence of current
suicidal ideation was 27.3% (95%CI: 21.4–33.5%), the pooled prevalence
of lifetime suicidal ideation was 47.3% (95%CI: 39.7–54.8%), and the
pooled prevalence of lifetime suicide attempts was 13.5% (95%CI:
12.3–14.7%). Suicide attempts rates were positively associated with in-
crease in severity of obsessions, proportion of comorbid substance use
and severity of depressive/anxious symptoms, whereas suicide at-
tempts rate decreased as severity of compulsions increased. In contrast,
suicidal ideation rate was positively associated with severity of obses-
sions, lower education, higher unemployment rates, lifetime alcohol
use disorders, personality disorders and family history of completed
suicide [1]. Interestingly, whereas a lifetime diagnosis of comorbid
Anxiety Disorder was associated with lower rates of suicidal ideation,
the severity of comorbid anxiety symptoms was positively related to
suicidal ideation prevalence [1]. The authors concluded that these
factors should be used to inform a suicidal risk assessment that should
be factored into the assessment of all cases of OCD.
Less is known about suicidality and other OCRDs included in the
DSM-5. Only one previous meta-analysis examined the strength and
patterns of the association between suicidality and BDD, concluding
that BDD is associated with increased odds for both suicide attempts
and suicidal ideation [2], with a positive and statistically significant as-
sociation found between BDD and suicidality (OR: 3.63, 95% CI: 2.62 to
4.63). However, in this meta-analysis suicide attempts and suicidal ide-
ation were investigated together. This approach is not ideal, as suicidal
thoughts and acts may be mediated by different mechanisms (neural,
psychological, behavioural) and, as described above, may be linked to
different risk factors. Moreover, it is important to investigate the history
of suicide attempts separately, as this factor usually constitutes the
strongest predictor of completed suicide [25]. The meta-analysis by
Angelakis and colleagues [2] had another limitation: the authors did
not separate current and lifetime suicidal ideation when estimating
the effect size of the association between suicidal ideation and OCD.2
Moreover, since this meta-analysis was published, much new data has
emerged concerning the prevalence of suicide attempts and suicidal
ideation and factors associated with increased risk in BDD. No similar
studies are available for the other disorders of the OCRDs chapter.
Given the relatively high prevalence of OCRDs in the general popula-
tion, estimated in one analysis to account for around 10% [26], and the
impact in terms of psychosocial impairment associated with these dis-
orders, the investigation of suicidality and the identification of potential
socio-demographic and clinical factors that could increase the risk for
suicide is of considerable clinical relevance.
Theassociationbetweensuicidality andOCRDswas the focusof a sys-
tematic reviewour researchgrouprecentlypublished [24]. This previous
work raised interest in the topic of suicidality inOCRDsasa groupbutdid
not include a quantitative meta-analysis. A subsequent meta-analysis
was performed by the same authorship group, which investigated OCD
only [1]. In the current paper, we extend a similar quantitative statistical
approach to the investigation of the remainingDSM-5OCRDs based on a
comprehensiveanalysis of all therelevantpublished literature, including
the results from a fewpapers published after 2018.
The primary aimof the present systematic review andmeta-analysis
was to estimate the pooled prevalence of lifetime suicide attempts,
current suicidal ideation and lifetime suicidal ideation in individuals
with a primary diagnosis of Obsessive-Compulsive Related Disorders
(excluding OCD). Our second aim was to identify, when possible, with
meta-regression and subgroup analyses, which study characteristics
or socio-demographic and clinical factors explain the variability in
prevalence rates.
2. Materials and methods
The protocol for this systematic review and meta-analysis was pre-
registered with PROSPERO (CRD42020164395). The work was con-
ducted following the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses Statement (PRISMA) [27].
2.1. Search strategy
We conducted a literature search in PubMed/Medline, PsycINFO,
Web of Science and CINAHLdatabases from thedate of thefirst available
article (1993) to April 30th, 2020. The following search terms were
used: (suicide OR suicidality OR suicide attempts OR suicidal ideation
OR suicidal thoughts) AND ((BDD OR body dysmorphic disorder) OR
(HD OR hoarding disorder) OR (trichotillomania OR hair pulling disor-
der) OR (excoriation disorder OR skin picking disorder)).
2.2. Article selection and review strategy
Articles were identified and assessed for eligibility by two reviewers
(UA and LP), who independently decided which articles to include ac-
cording to eligibility criteria (see below). In case of disagreement, a
third author (GM) was consulted to reach consensual decisions. Dupli-
cate studieswere excluded. Cross-references from the articles identified
were also examined. Unpublished studies, conference abstracts or
poster presentations were not included. The database search was re-
stricted to English language papers.
2.3. Eligibility criteria
The inclusion criteria for the studies were the following: 1) An ap-
propriate case definition of OCRDs (diagnosis made through structured
clinical interviews and/or standardized international criteria); 2) Chil-
dren/adolescents and/or adults; 3) Cross-sectional or prospective in
design; 4) Performed in clinical samples or in the general population
(epidemiological studies); 5) Employed a quantitative measure of
suicidality in order to derive prevalence rates of lifetime suicide at-
tempts, current or lifetime suicidal ideation. We excluded studies
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(e.g., individuals with Bipolar Disorder or Schizophrenia) even when
they assessed the impact of obsessive-compulsive symptoms on
suicidality.
2.4. Data extraction and imputation
Two authors (LP and UA) independently extracted the following
variables (identified based on previous literature [22,23], and pre-
registered on Prospero) from appropriate studies when available: date
of publication, country, geographic area (North America, South
America, Europe, Asia and Africa), study design (cross-sectional, longi-
tudinal), population type (clinical, general), total sample size, gender
distribution, mean age, age group (adults, children/adolescents,
mixed), percentage married, years of education, percentage unem-
ployed, diagnostic criteria for OCRDs, method used to diagnose OCRDs
(clinical interview, semi-structured interview such as SCID-I [28,29],
or MINI [30]), age at symptoms onset, age at disorder onset, duration
of illness (years), severity of symptoms (e.g., Yale-Brown Obsessive-
Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-
YBOCS) [31], Saving Inventory Revise (SIR) [32], percentage with
childhood trauma, percentage with Axis I comorbidities (current and
lifetime separately), percentagewithmood disorders,Major Depressive
Disorder, Bipolar Disorder, Anxiety Disorders, Substance Use Disorders,
Alcohol Use Disorder (current and lifetime), percentage with Axis II co-
morbidities/Personality Disorders, severity of depressive symptoms
(measured with the Hamilton Depression Rating Scale (HDRS) [33],
Montgomery-Asberg Depression Rating Scale (MADRS) [34], or Beck
Depression Inventory (BDI) [35]), severity of anxiety symptoms (mea-
sured with the Hamilton Anxiety Rating Scale (HARS) [36] and Beck
Anxiety Inventory (BAI) [37]), hopelessness (Beck Hopelessness Scale
(BHS) [38]), screening tool for suicidality, family history for suicide at-
tempts and for completed suicide.
2.5. Appraisal of methodological quality
The methodological quality of the studies was assessed by two
independent raters (LP and UA) using a modified version of the
Quality Assessment Tool (QAT) for Observational Cohort and Cross-
Sectional Studies (https://www.nhlbi.nih.gov/health-topics/study-
quality-assessment-tools. The tool consists of 14 items that address
specific methodological issues. We excluded five items that did not fit
with the nature of most studies here considered: item 5 (sample selec-
tion procedures), item 6 (exposure assessed prior to outcomemeasure-
ment), item 10 (repeated measurement of the exposure), item 12
(blinded outcome measurement) and item 13 (follow-up loss rates).
For each item satisfied, a pointwas assigned (yes=1; itemnot satisfied
or for which no sufficient information was available = 0). A sum score
ranging from 0 to 9 was then calculated.
2.6. Statistical analyses
A systematic analytical approach was used to compute the pooled
prevalence rates of lifetime suicide attempts, current suicidal ideation
and past suicidal ideation from all eligible studies separately for each
disorder group. In the case of SPD and TTM, as the number of studies
was too small to be investigated in separate analyses (respectively
N=4 for SPD, N=3 for TTM and N=1 for SPD + TTM considered al-
together), these two disorders were analysed together as Grooming
Disorders. The Stata command metaprop was used to perform meta-
analyses of proportions, to derive pooled estimates, to obtain exact
binomial confidence intervals and to produce forest plots. The pooled
estimates were calculated after Freeman-Tukey Double Arcsine Trans-
formation [39] to stabilize the variances. A random-effects model was
selected to summarize the prevalence of lifetime suicide attempt,3
current suicidal ideation and past suicidal ideation, using proportions
and 95% confidence intervals (CIs).
The pooled prevalence rates and their 95% CIs were compared be-
tweendisorder groupsandused todetect any significantdifference.Het-
erogeneity among studieswas assessed using Cochran's Q test and the I2
statistic. I2 > 50% was considered to denote substantial heterogeneity
and in such cases the sources of heterogeneity were explored. Subgroup
analyses by type of population (general, clinical), age group (adults, ad-
olescents, mixed) and geographical area were performed to investigate
heterogeneity. In addition, the effect of continuous covariateswas tested
by univariate randommeta-regression based on the Der Simonian and
Laird (1986) [40]method.We used themethod of moments to estimate
the additive (between-study) component of variance τ2. Meta-
regressions were performed when a covariate was available for at least
four studies. Publication bias was assessed in meta-analyses with ≥8
studies by means of funnel plots and Egger's test. Sensitivity analyses
were carried out in order to assess the robustness of our findings. A pri-
mary sensitivity analysis included studies with medium-high quality
(QAT score ≥ 7); in a secondary sensitivity analysis, the leave-one-out
approachwasused to evaluate the influence of each study on thepooled
prevalence. The significance level was set at p<0.05. All statistical anal-
yses were performed using Stata version 15 (StataCorp, 2017. Stata Sta-
tistical Software: Release 15. College Station, TX) [41].
3. Results
ThePRISMAflowchartof studies selectedand included in thesystem-
atic review andmeta-analysis is provided in Fig. 1. The search strategy
yielded 1498 articles, 95 of which were eligible for full-text screening.
As shown in theflowchart (Fig. 1), 38 studieswith independent samples
were included in the final quantitative analysis.We excluded 20 articles
as theywere based on the same sampleof participants (seeAppendix 1).
Completed suicide rates were not included in the meta-analysis as
there were not enough studies reporting data on completed suicide.
Tables 1A, 1B and 1C summarize the characteristics of the 38 studies
(N = 4559 individuals), 23 for BDD, 8 for HD, 7 for GD, included in the
meta-analysis.
The majority of studies were conducted in USA (16, 41.0%), Europe
(N = 10, 28.2%), and Brazil (n = 7, 17.9%). The majority of studies in-
cluded participants from clinical populations and only four were con-
ducted in the general population; all had a cross-sectional design
except two studies which had a longitudinal design [56,77]). Gender
distribution was similar among studies (only one study [49] included
exclusively females). The mean age of the study samples ranged be-
tween 13.7 [50] and 67 years [66], with three studies investigating spe-
cifically children/adolescent [41,50,52]. Most studies included only
adults (≥18 years of age).
The most widely used tools for assigning a diagnosis of OCRD was
the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I).
Suicidality was assessed using different instruments, only some of
which were specifically designed to inquire about suicidality
(e.g., Beck Suicide Intent Scale - SIS [81] in Alonso et al. (2010) [64];
Scale for Suicidal Ideation – SSI [82] in Balci & Sevincok (2010) [68]). Co-
lumbia Suicide Severity Rating Scale (C-SSRS) [83] in Snorrason et al.
(2019) [61]. The study quality (assessed with the QAT modified) was
relatively homogeneous, as shown in the Supplemental materials (see
Tables 1A, 1B, 1C in Supplemental materials). None of the studies had
a low quality in data reporting (QAT score ≤ 3), only 3 studies had a
score of 4, while themajority (N=21, 53.8%) had moderate-high qual-
ity (QAT score ≥ 7).
3.1. Lifetime suicide attempts in OCRDs
The forest plot with all the studies investigating lifetime suicide at-
tempts in OCRDs is shown in Fig. 2. In this forest plot, the updated
pooled prevalence of attempts in OCD is also shown for comparison.
Fig. 1. Flow chart of the studies.
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OCRD: 16 in BDD, 6 in HD and 6 in Grooming Disorders, with overall
random-effects pooled rates of 35.2% (95%CI: 23.4–47.8%), 24.1%
(95CI%: 12.8–36.7) and 13.3% (95%CI: 5.9–22.8%), respectively. Hetero-
geneity was high in all three disorders.3.1.1. Lifetime suicide attempts in BDD
In BDD, the studies reported rates of lifetime suicide attempts rang-
ing from 7% to 97%. The random-effect meta-analysis of lifetime suicide
attempts rates revealed a large heterogeneity among studies, I2 =
91.4%, with 2 studies exceeding the upper boundary of the confidence4
interval of the pooled estimate [46,60]. The funnel plot and Egger's
test indicated the absence of publication bias (Supplemental Fig. 1).
In a sensitivity analysis including moderate-high quality studies
(N = 11) pooled prevalence and heterogeneity were similar to those
of the primary analysis (pooled rate = 37.8%, 95%CI: 23.3–53.4%, I2 =
93.4%) (Supplemental Fig. 2). When sensitivity analyses with the
leave-one-out approach were conducted, excluding the study by
Semiz et al. 2008 [60], the pooled prevalence dropped from 35% to
29%, with heterogeneity remaining high (I2 = 83.3%) (Supplemental
Fig. 3).
In subgroup analyses, we found significant differences in prevalence
by type of population and geographical area. Studies in the general
Table 1A
Suicidality in BDD – Descriptive characteristics of studies included in the meta-analysis (N = 23).
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30 57.0 M = 33.2
(SD = 11.3)
(continued on next page)
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16 25.0 M = 31.6
(SD = 10.8)
Note: M = mean; SD= standard deviation; n/r = not reported.
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attempts of 14.2% (95%CI: 7.4–22.5) compared to studies in clinical sam-
ples (rate of 38.9.% (95CI%: 25.7–52.9)) (Fig. 3).
Only one study was conducted in South America [47] and this re-
ported a lower prevalence of lifetime suicide attempts of 15% (95%CI:
3.2–37.9). One studywas conducted in Asia with a very high prevalence
of 97.4% (95%CI: 86.2–99.9) [60], 4 in Europewith a pooled rate of 18.1%
(95%CI: 10.4–27.2) and a degree of heterogeneity of 49.8% and 11 in
North America with a pooled prevalence of 36.4% (95%CI: 25.2–48.3)
and heterogeneity of 84.2% (Supplemental Fig. 4). Age groups did not
significantly account for the observed heterogeneity. Univariate meta-
regression analyses carried out on the subsets of studies for which the
covariate of interest was available (age, disease severity, comorbidities
and family history of suicide), showed that only substance usewas asso-
ciatedwith a significantly increased prevalence (9 studies, b=0.905, se
(b) = 0.348, p = 0.009, R2 = 39.55%) (see Fig. 4).3.1.2. Lifetime suicide attempts in HD
In HD prevalence ranged from 6.5% [65] to 75.9% [70]. The overall
pooled rate was 24.1% (95%CI: 12.8%–37.6%).
Amongmedium-high quality studies (N=4) the pooled prevalence
dropped from 24.1% to 15.7% (Supplemental Fig. 5), but heterogeneity
remained high 80%. In the sensitivity analyses with leave-one-out ap-
proach, by excluding the study by Matsunaga et al., 2010 [70], the
pooled prevalence dropped further to 14.4% (Supplemental Fig. 6).6
All the studies included clinical populations. Similarly to the results
in BDD, the studies in HD conducted in Asia (N = 2) reported higher
prevalence of lifetime suicide attempts (Supplemental Fig. 7).
No difference was found between studies including adults only and
those including both adults and adolescents. In meta-regression analy-
sis, there was a negative association between years of education and
lifetime suicide attempts (4 studies, b = −0.195, se(b) = 0.065, p =
0.003, R2 = 67.02%) (see Fig. 5).
3.1.3. Lifetime suicide attempts in grooming disorders
For Grooming Disorders, the pooled prevalence of lifetime suicide
attempts was 13.3% (95%CI: 5.9% - 22.8%), with a minimum of 3.7%
[79] and a maximum of 33.3% [75], degree of heterogeneity was 76.5%.
All the six studies had poor quality (QAT score < 7) and in leave-
one-out sensitivity analysis none of them significantly affected the
pooled prevalence estimate. The studies included clinical populations
and no difference in prevalence estimates was found by geographical
area or age groups (adults or adolescents). No variable accounting for
significant heterogeneity among the studies was identified in the
meta-regression analyses.
3.2. Current suicidal ideation in OCRDs
For current suicidal ideation, we found 19 studies (11 studies for
BDD, 5 for HD, 3 for GroomingDisorders). Fig. 6 shows the forest plot in-
cluding all the disorders.
Table 1B
Suicidality in HD – Descriptive characteristics of studies included in the meta-analysis (N = 8).














Spain Cross-sectional CY-BOCS Symptom Checklist Open question as part of
clinical interview, Item of
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528 39.2 M = 35.9
(SD = 13.2)
Note: M = mean; SD= standard deviation; n/r = not reported.
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The overall random-effects pooled prevalence of current suicidal
ideation in the 11 studies for BDD was 37.2% (95%CI: 23.8–51.6%),
with a heterogeneity I2 = 87.8%. The funnel plot and Egger's test
did not indicate the presence of publication bias (Supplemental
Fig. 8).
Results from sensitivity analysis including studies with moderate-
high quality (N = 8) were similar to those of the primary analysis
(pooled rate: 36.3%, 95%CI: 19.7–54.8%, I2 = 91.3%) (Supplemental
Fig. 9). In a sensitivity analysis omitting the outlier study by Snorasson
et al., (2019) [61] (prevalence of 91.7%), the overall pooled rate de-
creased from 37.2% to 30.6% and the heterogeneity dropped from
87.8% to 57.7% (Supplemental Fig. 10).
Subgroup analysis revealed no significant study variations among
geographical area or among age groups. A higher prevalence was
found in the clinical samples (40.3%) compared to the general popula-
tion samples (25.8%), but the difference was not significant (Supple-
mental Fig. 11). No variable accounting for significant heterogeneity
among the studies was identified in the meta-regression analyses.7
3.2.2. Current suicidal ideation in HD
The overall random-effects pooled prevalence of current suicidal
ideation in the 5 studies for HD was 18.4% (95%CI: 10.2–28.3%), with a
high heterogeneity (I2 = 91.8%) (see Fig. 6).
In the sensitivity analysis based on moderate-high quality studies
(N =3) pooled rate and heterogeneity dropped to 10.9% (95%CI:
6.3–16.5%) and 61% respectively (Supplemental Fig. 12). Similarly, in
the sensitivity analyses using the leave-one-out approach, by excluding
the outlier study by Ayers et al. 2015 [67], the pooled prevalence rate
dropped to 10.8% (95%CI: 8.1–13.7) and the heterogeneity declined
from 91.8% to 43.7% (Supplemental Fig. 13).
The studies were all cross-sectional except one with a longitudinal
design [57] and all involved clinical populations. One study that was
conducted in Asia [68] and another conducted in North America [67] re-
ported higher rates (36.4% and 46.5%, respectively).
3.2.3. Current suicidal ideation in grooming disorders
Only 3 studies investigated current suicidal ideation in the grooming
disorders and found an overall random-effects pooled prevalence 40.4%
Table 1C
Suicidality in GD – Descriptive characteristics of studies included in the meta-analysis (N = 8).
















USA Cross-sectional Clinical interview n/r Suicide attempts Individuals
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USA Cross-sectional Clinical interview based on proposed
diagnostic criteria for PSP
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with OCD or
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Cross-sectional Self-report questionnaire based on
DSM-IV diagnostic criteria for
Trichotillomania










USA Longitudinal Minnesota Trichotillomania
Assessment Inventory
n/r Suicide attempts Individuals
with
16 12.5 M = 39.0
(SD = 12.0)
Note: M = mean; SD= standard deviation; n/r = not reported.
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no significant heterogeneity, therefore we didn't run subgroup, meta-
regression or sensitivity analyses.
3.3. Lifetime suicidal ideation in OCRDs
12 studies reported data on lifetime suicidal ideation in the OCRDs,
10 for BDD and only 2 for HD; no study was available for this metric in
grooming disorders (see Fig. 7).
3.3.1. Lifetime suicidal ideation in BDD
In BDD, the overall random-effects pooled lifetime prevalence was
0.661 (95% CI: 0.535–0.777), with a heterogeneity of I2 = 87.2%
among studies. The funnel plot and Egger's test indicated the absence
of publication bias (Supplemental Fig. 14).
Among moderate-high quality studies (N = 6) the pooled preva-
lence was slightly higher (72.2%, 95%CI: 59.3–83.6%), but heterogeneity
remained high (I2 = 87.9%) (Supplemental Fig. 15). In leave-one-out
sensitivity analyses, none of the studies significantly affected the pooled
prevalence estimate.
The lowest prevalence was observed for the European study [45]
conducted on general population. Studies conducted in Europe (N = 2)
reported a much lower pooled prevalence (46%) than those from North
America (70.9%). However, heterogeneity within the two geographical
areas remained high (Supplemental Fig. 16). Age groups did not signifi-
cantly account for the observed heterogeneity. Meta-regression analyses
in BDDdid not identify any factors associatedwith increased rates of life-
time suicidal ideation.
3.3.2. Lifetime suicidal ideation in HD
Only two studies conducted in Brazil investigated lifetime suicidal
ideation in HD, and had similar results, with a pooled prevalence of
38.3% (95% CI: 35.0–41.6%).
4. Discussion
This meta-analysis of 38 independent studies for the first time
shows that OCRDs as a group are at increased risk of lifetime suicide at-
tempts and suicidal ideation. Our findings support the review of
Angelakis and colleagues (2015) [20], which challenged the historical8
prejudice that OCD is not a disorder characterized by high risk of suicide
and in which the pooled effect size of the association between OCD and
suicidality was estimated to be moderate to high (Hedges' g for suicide
attempts: 0.64 and for suicidal ideation: 0.86), notwithstanding a high
degree of heterogeneity [20]. A recent meta-analysis of 61 independent
studies from our research group on suicidality in OCD for the first time
provided accurate estimates of the prevalence of lifetime suicide at-
tempts and suicidal ideation in individuals with a primary diagnosis of
OCD, suggesting that individuals with OCD are at increased risk of sui-
cide. Another meta-analysis by Angelakis and colleagues showed that
BDD is also at increased risk [2]. No previous work has been conducted
for the OCRDs as a group in order to compare suicide rates between the
different disorders.
As we anticipated in our pre-registered protocol, in this meta-
analysis the disorder with the highest pooled rate of lifetime suicide
attempts is BDD (35.2% (95%CI: 23.4–47.8%)) and numerically
exceeded the rate found for OCD in our recent meta-analysis (13.5% -
95%CI: 12.3–14.7%) [1]. Moreover, as the confidence intervals in this
study did not overlap with the analogous confidence intervals in the
previous OCD analysis, the values are likely to be significantly different
(however, the comparisons are indirect andmethodological differences
such as sample characteristics and type of assessment might act as
confounders).
The pooled rate of lifetime suicide attempts in BDD was also
greater than that found for HD and Grooming Disorders (without
reaching significance). The prevalence of lifetime suicide attempts
in HD (24.1% - 95%CI: 12.8–37.6%) was also substantially greater
that the rate previously found for OCD, but without reaching statisti-
cal significance (confidence intervals overlapping). The pooled life-
time rate of suicide attempts present in the Grooming Disorders
(13.3% (95%CI: 5.9–22.8%)) was very similar to that found previously
for OCD.
Concerning current suicidal ideation, in contrast to attempts, the dis-
orders with the highest prevalence are the Grooming Disorders (40.4%
(95%CI: 35.7–45.3%), (only 3 studies available, all of three reporting
very similar rates)), followed by BDD 37.2% (95%CI: 23.8–51.6%). The
pooled rate of current suicidal ideation inGroomingDisorders is numer-
ically higher than that of OCD (27.3% - 95%CI: 21.4–33.5%). The disorder
with the lowest rate of current suicidal ideation is HD (18.4% (95%CI:
10.2–28.3%)).
Fig. 2. Prevalence of suicide attempts in individuals with OCRDs. Random-effects meta-analysis.
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than those seen in the general population: For example, in the World
Health Organization (WHO) World Mental Health (WMH) Survey, in
which 108,705 adults from 21 countries were interviewed, 12-month
prevalence estimates of suicide ideation, plans, and attempts are 2.0%,
0.6%, and 0.3%, respectively, for developed countries and 2.1%, 0.7%,
and 0.4%, respectively, for developing countries [84]. We need to bear
in mind that a history of previous suicide attempts represents the
main risk factor for completed suicide [25]. Regarding suicide attempts,
the rates in BDD are close to those reported for schizophrenia (39.2%
[85]) and higher than the rates in affective disorders (29.2% in bipolar
disorder - 15.9% in unipolar depression [86]).
The clinical implication of these results is that clinicians should keep
inmind that patients with OCRDs as a whole are at a relatively high risk
of suicidal behaviour and this should be actively inquired about, includ-
ing suicidal ideation, plans, personal history of previous suicide at-
tempts. Indeed, a recent meta-analysis suggests that some kind of
suicide communication occurs in about half of the individuals who
eventually die by suicide [87]. Active inquiry is recommended, as it is
likely that some individuals would not spontaneously disclose
suicidality, as this class of disorders is known to be associated with se-
crecy and shame [88], which may have contributed to the historical
prejudice that these patients were not at risk. Clinicians should there-
fore pay specific attention to eliciting communications of suicidal inten-
tions, ranging from direct clues of the intention to commit suicide to
indirect signs (e.g., selling things or cleaning out an office or a bedroom
incongruously).9
In ourmeta-analysis, a large heterogeneitywas found among studies
(I2 with values between 76.5% and 95.4%). Rates of lifetime suicide at-
tempts in BDD from individual studies, for example, varied from 7.1%
[58] to 97.4% [60]. Through subgroup analyses and meta-regression,
we attempted to explain part of the heterogeneity. For BDD, we found
through subgroup analysis a significant difference in lifetime suicide at-
tempts by geographical area, with a very high rate in Asia (only one
study, Semiz et al., 2008 [60], 97.4%), a lower rate in Europe of 18.1%
(with heterogeneity dropping to 49.8%) and a prevalence of 36.4% in
North America (heterogeneity of 84.2%). As expected, studies in
community samples showed a lower rate of 14.3% (95%CI: 6.5–25.3)
compared to the rates in clinical samples (rate of 40.8% (95CI%:
26.8–55.6)), suggesting that the risk of suicide attempts in BDD is
more significant in individuals referred to treatment centers (presum-
ably with more severe or longstanding BDD).
A large proportion of patients with OCRDs did not have current or
lifetime suicidal ideation, nor did they attempt suicide in their lifetime.
This implies that differentiating the risk among patients by identifying
predictors of suicidality is of foremost clinical importance and could re-
sult in improving our ability to screen subjects at greater risk needing
more intensive and careful monitoring, so as to allocate clinical re-
sources accordingly.
In thismeta-analysis, we confirmed our a priori hypothesis, as stated
in the protocol pre-registeredwith PROSPERO (CRD42020164395), that
increased prevalence of substance use is significantly associated with
increased rates of lifetime suicide attempts in studies including patients
with BDD.
Heterogeneity  between groups: p = 0.001
Ov erall  (I 2̂ = 91.403%, p = 0.000);
Jaf f erany  et al. (2019)
Bjornsson et al. (b) (2013)
Buhlmann et al. (2010)
Rief  et al. (2006)
Subtotal  (I 2̂ = 91.731%, p = 0.000)
Fontenelle et al. (2006)
Bjornsson et al. (a) (2013)
Conroy  et al. (2008)
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Fig. 3. Prevalence of suicide attempts in individuals with OCRDs, by population type (general/clinical). Random-effects meta-analysis.
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without comorbid substance use, the rate of suicide attempts in individ-
uals with BDD and substance use was 38.4% and this rate dropped to
18.9% in individuals with BDD but without substance use [111].
Comorbid substance use therefore represents a potential risk factor
for suicide attempts in patients with BDD and should be explored in
clinical risk assessment.
Of the OCRDs, individuals with BDD are thought to show compara-
tively increased behavioural impulsivity [89], as exemplified by the
risky behaviours that are commonly present (e.g., problematic internet
usage [90], do-it yourself surgery [91]). Patientswith BDD also show rel-
atively high rates of abuse of different types of psychoactive substances
(alcohol but also other drugs such as steroids, cannabis, hallucinogens -
LSD, mescaline, magic mushrooms, etc. [92]) compared to OCD (mainlyFig. 4. Scatter plots showing the significant association between the prevalence of suicide
attempts (y axis) and substance use (x axis) in BDD.
10alcohol, [93]). Substance use is known to be a risk factor for suicide at-
tempts in OCD [1], as well as other severemental illnesses (Schizophre-
nia, Bipolar Disorder, Unipolar Disorder and Personality Disorders) [94],
suggesting this comorbidity may increase risk across many if not all
mental disorders. Clinicians should therefore actively inquire about con-
sumption of alcohol and/or other illicit substances in individuals pre-
senting with OCRDs, in order to identify those in need of closer
monitoring for suicide prevention.
Addictive behaviours and substance abuse in OCRDsmay also reflect
poorer latent impulse control, which may independently raise the risk
of suicidal behaviours. Poor impulse control has been linked to
suicidality in affective disorders such as Major Depression Disorder
and Bipolar Disorder [95]. OCRDs are already known to be associated
with poor impulse control when tested on laboratory-based tasks [96].
For example, patients with BDD show elevated reward-based impulsiv-
ity in the Cambridge Gambling Task [89]. The subgroup of patients with
OCRDs who abuse substances may represent a particularly impulsive
group. In a preliminary study, increased attentional impulsivity, mea-
sured through the Barratt Impulsiveness Scale, and poorer reward-
based decision making, measured through the Cambridge Gambling
Task,were identified in a subsample of patientswith OCD and comorbid
Alcohol Use Disorder compared to a non-comorbid subgroup [93].
Impulsivity and compulsivity are multidimensional constructs,
thought to be mediated by overlapping as well as distinct neural sub-
strates. Impulsivity can be fractionated into various different domains
e.g. motor, decision-making, reflection impulsivity [97]. The impact of
specific forms of impulsivity on suicidal behaviours within the OCRD
population merits further study. A recent study investigating suicidal
behaviour in patients with depression and anxiety [98] found that im-
pulsive decision making and risk taking on objective tests (Cambridge
Neuropsychological Test Automated Battery (CANTAB) [99] differenti-
ated those with suicidal ideation. To date, in studies of OCD, impulsive
decision making as measured by the Cambridge Gambling Task [99]
has only been inconsistently found [100,101], and perhaps when pres-
ent could indicate amore impulsive subgroup, potentiallywith a greater
risk of suicidal behaviour. If substantiated in other OCRDs, findings such
Fig. 5. Scatterplot showing the significant association between the prevalence of suicide
attempts (y axis) and the education years (x axis) in HD.
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trans-diagnostic markers of suicidality. For example, application of clin-
ical instruments, such as the Barratt Impulsiveness Scale [102] or evenFig. 6. Prevalence of current suicidal ideation in indivi
11neurocognitive tasks such as the Cambridge Gambling Task, could be
of potential value for routine use in the clinical setting to help identify
those with higher risk of suicidality.
HD showed a high rate of lifetime suicide attempts (24%) and a com-
paratively lower rate of current suicidal ideation (18.4%),while in all the
others OCRDs, the rate of current suicidal ideation was higher than the
rate of lifetime suicide attempts. It is possible that this finding could
be explained by the particular impulsivity profile and poor insight that
also characterizes individuals with this disorder [5,103]. We could
infer that patients with HD may not think much about killing them-
selves and may impulsively attempt suicide without premeditation.
This piece of information is important for clinicians to know, as individ-
uals with HD could possibly attempt suicide in a particularly unpredict-
able way (without significant premeditation). In other words, accurate
suicide risk assessment in patients with HD should not rely exclusively
on enquiry about the presence of suicidal ideation. Instead, especially
for HD, a previous history of impulsive behaviours and/or suicide at-
tempts is likely to be more relevant to assess current suicide risk.
In contrast, the number of educational years was associated with
lower rates of lifetime suicide attempts in HD. We hypothesize that
this finding could relate to the degree of cognitive impairment that is
recognized to be associated with this particular disorder [104]. Clini-
cians may therefore be guided by educational history when assessing
an individual with HD and consider poor education another possibleduals with OCRDs. Random-effects meta-analysis.
Fig. 7. Prevalence of lifetime suicidal ideation in individuals with OCRDs. Random-effects meta-analysis.
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conducted in Asia (N=2) reported amuch higher prevalence of suicide
attempters (67%) and a subgroup analysis by country for suicide at-
tempts in HD explained part of the heterogeneity between results (see
Fig. 6). A similar difference in suicide attempts by geographical area
was found in BDD, where studies conducted in Asia also reported a
higher prevalence of attempts. Explanations for this finding could be
several and cultural factors could come into play.
As to current suicidal ideation, we found that the disorders with the
highest rates were the Grooming Disorders (only three studies were
available and all gave similar rates) and BDD.Our results suggest that in-
dividuals with Grooming Disorders still think a lot about suicide even if
they do not put it into action asmuch as do the other OCRDs. Thefinding
that the lifetime suicide attempt rates in Grooming Disorders do not
reach the high rates seen in HD and BDD, hints at the presence of
some kind of protective factor at play in the Grooming Disorders, that
we are not able to fully explain in this presentwork. It is possible, for ex-
ample, that those disorders characterized by a more habitual behaviour
pattern (SPD and TTM) with comparatively less involvement of the “af-
fective” brain circuitry and more involvement in the “cognitive-execu-
tive” circuits [105], could be at lesser risk than those disorders
characterized by a greater affective component and cognitive burden
(BDD, HD and OCD).
4.1. Limitations and strengths
We could not include completed suicide rates in the quantitative
analyses, as such data in OCRDs are scant. Presumably, a long dura-
tion of illness, which increases the risk of socio-functional12impairment and secondary depression, and a long duration of un-
treated illness, which is an unfavourable prognostic factor, increase
suicide risk in OCRDs. Regrettably, we were not able to quantita-
tively explore this association due to the shortage of studies
reporting information on duration of illness/untreated illness and
suicidality. Themost updated and large epidemiological study inves-
tigating complete suicide rates in OCD [106], found that these pa-
tients had an increased risk of dying by suicide in a 44-year study
period (unadjusted OR: 9.83, incidence rate: 1.48%). No similar lon-
gitudinal studies have been published for other OCRDs. It may be
that, as seen in studies of affective disorders [107], factors associated
with suicide attempts and suicidal ideation are different from those
predicting completed suicide. Future prospective studies are needed
to address this specific issue and progress from hypotheses gener-
ated through tests of association to confirmatory analyses with spe-
cific reference to the population with OCRDs.
The main limitation of our analysis is that the number of the studies
investigating suicidality in some OCRDs, in particular Hoarding Disor-
der, Trichotillomania and Skin Picking Disorder, is limited. This forced
us to merge Trichotillomania and Skin Picking Disorder into the sub-
group of Grooming Disorders, due to their similar psychopathological
and neurocognitive features [105].
Despite establishing strict criteria for the inclusion of studies in the
meta-analysis, a wide heterogeneitywas found in the prevalence of life-
time suicide attempts and suicidal ideation that to some extent limits
our confidence in the findings. However, by performing several sub-
group and meta-regression analyses, we attempted, when possible, to
identify various factors that explained this heterogeneity that we inte-
grated in our interpretation of results.
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sults, is the use of different instruments to assess suicide attempts and
suicidal ideation in several of the studies included in the meta-
analysis. Fifteen studies (38.4%) used open-ended questions as part of
the clinical interview to obtain information about lifetime suicide at-
tempts or suicidal ideation, or not validated specifically designed ques-
tionnaires. Some of the studies used a single item of a more complex
rating scale (e.g. the Hamilton Depression Rating Scale (HAM\\D)),
others used specific validated scales (e.g. Scale for Suicidal Ideation
(SSI) - Balci & Sevincok (2010) [68], Beck Suicide Intent Scale (SIS) -
Alonso et al. (2010) [65]), and only 1 study (Snorrason et al. (2019)
[61]) used the Columbia Suicide Severity Rating Scale (C-SSRS), a spe-
cific instrument which allows the dimensional analysis of suicidal idea-
tion, its severity and suicidal behaviours.Moreover, the largemajority of
the studies included were cross-sectional; combined with the lack of
use of specific instruments, this can make the estimate of suicide at-
tempts or suicidal ideation rates in that specific study unreliable. The
lack of a shared nomenclature to define suicide related terms is a com-
mon issue in studies investigating suicidal ideation and behaviours, as
well as the lack of lethality assessment of attempts. Future studies
with a longitudinal design and proper definition of suicide phenomena
[108,109], should further investigate this topic in OCD in order to ad-
vance suicide research and prevention.
Despite these limitations, our meta-analysis has several strengths;
for the first time it investigates suicidality in several OCRDs and aims
to find differences in suicide rate in this group of different disorders.
Our work includes a significant number of studies (N= 38), both clini-
cal and epidemiological ones, most of moderate/good quality, per-
formed in individuals of all ages with a primary diagnosis of OCRDs.
Only three studies investigated suicidality in children with OCD and
we have identified this lack of data as an evidence gap that needs to
be filled with future research. Moreover, to examine the potential con-
tribution to suicidality of several generic/transdiagnostic factors,
OCRD-specific factors and comorbidities, we considered separately fac-
tors potentially contributing to increasing suicide attempts and those
contributing to suicidal ideation. We pre-registered the protocol of
this meta-analysis on the International Prospective Register of System-
atic Reviews Prospero (Center for Reviews and Dissemination, Univer-
sity of York) and the findings are in line with our a-priori hypotheses.
5. Conclusions
Our study builds upon previous results showing that individuals
with OCD are at significant risk for thinking about and attempting sui-
cide. For the first time, we separately collected data on suicidal ideation
and suicide attempts in the other OCRDs. Our findings show that about
one out of three patients with BDD, about one out of four with HD and
about one out of ten with Grooming Disorders attempts suicide during
his/her lifetime. Of all the OCRDs, BDD carries the highest risk of suicide
attempts and substance use could be a red flag that might increase the
risk both in OCD and BDD. Despite modest rates of suicidal ideation,
HD also presents a high risk of lifetime suicide attempts, with poor ed-
ucation also potentially representing a red flag. Clinicians are recom-
mended to use this information to carefully assess suicidality in
patients with all types of OCRD.
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